Lilly trumpets heart health data with Mounjaro Eli Lilly has raised the stakes in its rivalry with Novo Nordisk on GLP-1 drugs for diabetes, with new data for Mounjaro on cardiovascular outcomes.

#weightloss #weightlossmedications #obesity #Lilly #EliLilly #hearthealthdata #Mounjaro #tirzepatide #GLP1agonists #cardiovascularoutcomes #SURPASSCVOTtrial #dualGLP1GIPagonist #GLP1drug #MACE #heartattackprevention #strokeprevention #MACEendpoints #CVD #cardiometabolichealth
zurl.co/9w8Sk

Global research trends on DPP-4 inhibitors and... : Annals of Medicine and Surgery cular safety and efficacy. This bibliometric analysis aims to provide insights into the global research landscape on DPP-4 inhibitors and cardiovascular outcomes (CVOs). Methods: A bibliometric ana...

Global trends in DPP-4 inhibitor research focus on #CardiovascularOutcomes like #HeartFailure and #AtrialFibrillation in type 2 #diabetes. Leading institutions and authors drive this evolving field. #DPP4Inhibitors journals.lww.com/annals-of-me...

Early Vascular Aging Determined by 3-Dimensional Aortic Geometry: Genetic Determinants and Clinical Consequences | Circulation BACKGROUND: Vascular aging is an important phenotype characterized by structural and geometric remodeling. Some individuals exhibit supernormal vascular aging, associated with improved cardiovascular ...

Penn Medicine #BioBank growing its impact: Discerning early aortic #aging from imaging data with links to adverse #CardiacRemodeling and poor #CardiovascularOutcomes www.ahajournals.org/doi/10.1161/... @ThePMBioBank #PMBB #TranslationalScience